Jean-Baptiste Alberge

16PUBLICATIONS
113CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer diagnosisMedical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 08, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Omar Nadeem, Michelle P Aranha, Robert A Redd

|Mar 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma.

Floris Chabrun, Daniel E Schwartz, Susanna Gentile

|Feb 26, 2026
At a crossroads: circulating tumor cells in myeloma.

Jean-Baptiste Alberge

|Aug 08, 2025
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors.

Elizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Ting Wu

|Jun 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).

Floris Chabrun, Daniel Schwartz, Susanna Gentile

|May 21, 2025
Genomic landscape of multiple myeloma and its precursor conditions.

Jean-Baptiste Alberge, Ankit K Dutta, Andrea Poletti

Pageof 3

Frequent Collaborators

13 joint publications

Irene M Ghobrial

5 joint publications

Gad Getz

4 joint publications

David M Cordas Dos Santos

3 joint publications

Ankit K Dutta